Therefore, the MIB1/ST7/IQGAP1 signaling axis is an important mediator of pancreatic cancer progression, and inhibiting MIB1 may prolong the survival of patients with pancreatic tumors. This evidence concerns the gene MIB1 and familial pancreatic carcinoma.